Raffa Wealth Management’s Altimmune ALT Stock Holding History

Raffa Wealth Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3	Closed	-$232	–	258
2017 Q3	$232	Hold	3	–	–	﹤0.01%	276
2017 Q2	$320	Buy	+3	New	+$499	﹤0.01%	394

Other funds holding ALT

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Quadrant Glendale, California $18M AUM 24.2% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Raffa Wealth Management's ALT Position: Q4 2017 in Review

Raffa Wealth Management sold out of Altimmune (ALT) in Q4 2017, closing a stake of 3 shares — an estimated $232 sold.

Raffa Wealth Management first reported a position in ALT in Q2 2017 and held it in 2 quarters. The position peaked at $320 in Q2 2017. 30 funds tracked by Wall St. Rank hold ALT as of Q4 2017.

Raffa Wealth Management reported no remaining Altimmune position as of Q4 2017 after selling out during the quarter.
Raffa Wealth Management sold 3 Altimmune shares in Q4 2017, an estimated $232.
Raffa Wealth Management first reported a position in Altimmune in Q2 2017 and held it in 2 quarters.
Raffa Wealth Management's Altimmune position peaked at $320 in Q2 2017.
30 funds tracked by Wall St. Rank held Altimmune as of Q4 2017.

Based on Raffa Wealth Management's 13F filing for Q4 2017, filed 27 Jul 2026.